Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1985 Oct;48(10):989–994. doi: 10.1136/jnnp.48.10.989

Suspected and clinically definite multiple sclerosis: the relationship between CSF immunoglobulins and clinical course.

A J Thompson, M Hutchinson, E A Martin, M Mansfield, A Whelan, C Feighery
PMCID: PMC1028536  PMID: 4056815

Abstract

CSF immunoglobulins were examined in 103 patients with clinically definite multiple sclerosis, 106 patients with either suspected or progressive possible multiple sclerosis and 72 patients with other neurological diseases. Raised CSF IgG index and oligoclonal banding were found in 71% and 75% of clinically definite multiple sclerosis patients respectively and both tests were abnormal in 11% of patients with other neurological diseases. The CSF IgG index and the presence of oligoclonal IgG did not relate to the severity or duration of established disease in these patients. In patients with suspected and progressive possible multiple sclerosis, both a raised IgG index and the presence of oligoclonal banding were found significantly more frequently than in the OND group. Abnormalities of these parameters were significantly correlated with the presence of an abnormal evoked response in these patients (chi 2 = 10.16 p less than 0.01). When 47 patients with suspected multiple sclerosis were studied prospectively the presence of oligoclonal banding at presentation was associated with development of further disease activity.

Full text

PDF
989

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hutchinson M., Blandford S., Glynn D., Martin E. A. Clinical correlates of abnormal brain-stem auditory evoked responses in multiple sclerosis. Acta Neurol Scand. 1984 Aug;70(2):90–95. doi: 10.1111/j.1600-0404.1984.tb00808.x. [DOI] [PubMed] [Google Scholar]
  2. Hutchinson M., Martin E. A., Maguire P., Glynn D., Mansfield M., Feighery C. Visual evoked responses and immunoglobulin abnormalities in the diagnosis of multiple sclerosis. Acta Neurol Scand. 1983 Aug;68(2):90–95. doi: 10.1111/j.1600-0404.1983.tb04822.x. [DOI] [PubMed] [Google Scholar]
  3. Kurtzke J. F. Neurologic impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand. 1970;46(4):493–512. doi: 10.1111/j.1600-0404.1970.tb05808.x. [DOI] [PubMed] [Google Scholar]
  4. Laurenzi M. A., Link H. Comparison between agarose gel electrophoresis and isoelectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders. Acta Neurol Scand. 1978 Sep;58(3):148–156. doi: 10.1111/j.1600-0404.1978.tb02874.x. [DOI] [PubMed] [Google Scholar]
  5. Link H. Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin Chim Acta. 1973 Jul 27;46(4):383–390. doi: 10.1016/0009-8981(73)90251-9. [DOI] [PubMed] [Google Scholar]
  6. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand J Clin Lab Invest. 1977 Sep;37(5):391–396. doi: 10.1080/00365517709091497. [DOI] [PubMed] [Google Scholar]
  7. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest. 1977 Sep;37(5):397–401. doi: 10.1080/00365517709091498. [DOI] [PubMed] [Google Scholar]
  8. Livrea P., Trojano M., Simone I. L., Zimatore G. B., Lamontanara G., Leante R. Intrathecal IgG synthesis in multiple sclerosis: comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgG. J Neurol. 1981;224(3):159–169. doi: 10.1007/BF00313278. [DOI] [PubMed] [Google Scholar]
  9. McDonald W. I., Halliday A. M. Diagnosis and classification of multiple sclerosis. Br Med Bull. 1977 Jan;33(1):4–9. [PubMed] [Google Scholar]
  10. Moulin D., Paty D. W., Ebers G. C. The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis. Brain. 1983 Dec;106(Pt 4):809–816. doi: 10.1093/brain/106.4.809. [DOI] [PubMed] [Google Scholar]
  11. Perkin G. D., Sethi K., Muller B. R. IgG ratios and oligoclonal IgG in multiple sclerosis and other neurological disorders. J Neurol Sci. 1983 Aug-Sep;60(3):325–336. doi: 10.1016/0022-510x(83)90143-0. [DOI] [PubMed] [Google Scholar]
  12. Stendahl-Brodin L., Link H. Optic neuritis: oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol Scand. 1983 May;67(5):301–304. doi: 10.1111/j.1600-0404.1983.tb04579.x. [DOI] [PubMed] [Google Scholar]
  13. Stendahl-Brodin L., Link H. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1980 Feb;43(2):102–105. doi: 10.1136/jnnp.43.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thompson E. J., Kaufmann P., Shortman R. C., Rudge P., McDonald W. I. Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. Br Med J. 1979 Jan 6;1(6155):16–17. doi: 10.1136/bmj.1.6155.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tourtellotte W. W., Ma B. I. Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology. 1978 Sep;28(9 Pt 2):76–83. doi: 10.1212/wnl.28.9_part_2.76. [DOI] [PubMed] [Google Scholar]
  16. Walker R. W., Keir G., Johnson M. H., Thompson E. J. A rapid method for detecting oligoclonal IgG in unconcentrated CSF, by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining. J Neuroimmunol. 1983 Apr;4(2):141–148. doi: 10.1016/0165-5728(83)90018-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES